Immunotherapy is going to be the next big thing in cancer treatment. Someday cancer will be stopped at its tracks
Category: Vaccines
Lower Risk of Type 1 Diabetes in Children Vaccinated Against ‘Stomach Flu’ Virus
Vaccinating babies against a virus that causes childhood “stomach flu” greatly reduces their chance of getting so sick that they
Stalk antibodies provide flu protection in humans
A universal flu vaccine that could prevent a potential influenza pandemic has been a holy grail for epidemiologists around the
Vaccine one step closer for one of the world’s biggest killers
The search for a global Streptococcus A vaccine has narrowed after researchers sequenced the DNA of more than 2000 samples of the
McMaster researchers invent a way to get life-saving vaccines to previously inaccessible parts of the world
Researchers at McMaster University have invented a stable, affordable way to store fragile vaccines for weeks at a time at
Flu’s “hidden target” may lead to universal vaccine: study
Researchers at Vanderbilt University Medical Center and the Scripps Research Institute in La Jolla, California, have discovered a “hidden target”
One vaccine against two deadliest respiratory diseases in the world – influenza and pneumococcal infections won’t know what hit them
Vaccines are becoming more specialized. They work better and rarely cause unwanted side effects, but you need more of them.
NIH awards will advance development of vaccines for sexually transmitted infections
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced awards to
Snapshot of chikungunya could lead to drugs, vaccines for viral arthritis
Chikungunya virus, once confined to the Eastern Hemisphere, has infected more than 1 million people in the Americas since 2013,
Dyadic and Serum Institute of India to Develop and Manufacture Globally Affordable and Accessible Antibody Products and Vaccines
Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene
